Mayo Clinic Minute: Know The Warning Signs of Hypertrophic Cardiomyopathy

Translate to Spanish or other 102 languages!

It's often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people. Image for illustration purposes
It’s often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people. Image for illustration purposes
- Advertisement -

By Jason Howland / Mayo Clinic News Network

It’s often silent but can be a deadly killer. Hypertrophic cardiomyopathy is a genetic condition that occurs in 1 in 500 people.

Dr. Said Alsidawi, a Mayo Clinic cardiologist, says the problem is that many people don’t even know they have it because they have no symptoms. And in 20% of cases, the first presentation is sudden cardiac death. 

- Advertisement -

Watch: The Mayo Clinic Minute

Video courtesy of “Mayo Clinic News Network.” Read the script.

Hypertrophic cardiomyopathy is a genetic condition that causes the heart muscle to thicken, making it harder to pump blood and sometimes causing an irregular heart rhythm.

“So right now, what we think in the United States, we’ve only diagnosed 1/7 of the people who have hypertrophic cardiomyopathy. So we’re trying to increase the awareness in the community about this disease,” says Dr. Alsidawi.

He says patients are born with a genetic mutation. The disease can start at a young age or later in life — many times with no symptoms.  

- Advertisement -

“We know the patients that we lose to this condition, the majority of them are young, active and athletes. So high-level athletic exercise can put you at higher risk of sudden cardiac death,” says Dr. Alsidawi.

He says it’s important to seek medical attention if you have any symptoms, especially with exertion, “including shortness of breath, chest pain, lightheaded, dizzy or passing out.”

If diagnosed, the good news is hypertrophic cardiomyopathy can be treated with medications, surgery, implanting a defibrillator that monitors the heart or, in severe cases, heart transplantation.  

Additional resources:

Information Source: Mayo Clinic News Network

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

The Connection Between Diet and Breast Cancer Risk

October is Breast Cancer Awareness Month, and many people may be wondering how to lower their risk.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Simple Steps to Soothe Arthritis Pain

Mega Doctor News CLEVELAND CLINIC - Osteoarthritis is the most common form of...
- Advertisement -